Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|September 12, 2024
Complement-targeted therapeutics: Are we there yet, or just getting started?Daniel Ricklin
Immunobiology|September 12, 2012
Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapyDaniel Ricklin
Immunological Reviews|October 27, 2016
Preformed mediators of defense-Gatekeepers enter the spotlightDaniel Ricklin, John D Lambris
Seminars in Immunopathology|October 26, 2021
Tipping the balance: intricate roles of the complement system in disease and therapyRichard B Pouw, Daniel Ricklin
Immunobiology|June 24, 2015
Therapeutic control of complement activation at the level of the central component C3Daniel Ricklin, John D Lambris
Nature Biotechnology|November 9, 2007
Complement-targeted therapeuticsDaniel Ricklin, John D Lambris
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2013
Complement in immune and inflammatory disorders: therapeutic interventionsDaniel Ricklin, John D Lambris
Seminars in Immunology|August 16, 2016
Complement therapeuticsDaniel Ricklin, John D Lambris
Advances in Experimental Medicine and Biology|September 20, 2012
Progress and Trends in Complement TherapeuticsDaniel Ricklin, John D Lambris
Blood|September 21, 2013
TMA: beware of complementsDaniel Ricklin, Douglas B Cines
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|September 12, 2024
Complement-targeted therapeutics: Are we there yet, or just getting started?Daniel Ricklin
Immunobiology|September 12, 2012
Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapyDaniel Ricklin
Immunological Reviews|October 27, 2016
Preformed mediators of defense-Gatekeepers enter the spotlightDaniel Ricklin, John D Lambris
Seminars in Immunopathology|October 26, 2021
Tipping the balance: intricate roles of the complement system in disease and therapyRichard B Pouw, Daniel Ricklin
Immunobiology|June 24, 2015
Therapeutic control of complement activation at the level of the central component C3Daniel Ricklin, John D Lambris
Nature Biotechnology|November 9, 2007
Complement-targeted therapeuticsDaniel Ricklin, John D Lambris
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2013
Complement in immune and inflammatory disorders: therapeutic interventionsDaniel Ricklin, John D Lambris
Seminars in Immunology|August 16, 2016
Complement therapeuticsDaniel Ricklin, John D Lambris
Advances in Experimental Medicine and Biology|September 20, 2012
Progress and Trends in Complement TherapeuticsDaniel Ricklin, John D Lambris
Blood|September 21, 2013
TMA: beware of complementsDaniel Ricklin, Douglas B Cines
Pageof 14